Welcome to our dedicated page for Launch One Acquisition SEC filings (Ticker: LPAA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Launch One Acquisition Corp. filings document its status as a Cayman Islands blank-check company and the public security structure of LPAAU units, LPAA Class A ordinary shares, and LPAAW warrants listed on Nasdaq. The filings cover material-event reports, material agreements, shareholder voting matters, governance, capital structure, SPAC mechanics, operating results, and financial reporting.
Recent 8-K disclosure also records the termination of a prior business-combination agreement and related ancillary agreements, preserving the company's current SPAC disclosure focus.
Launch One Acquisition Corp. has terminated its planned merger with Minovia Therapeutics Ltd. and related parties. The companies signed a Termination and Release Agreement on January 30, 2026, which cancels the Business Combination Agreement and all ancillary agreements, leaving them with no further force or effect.
All parties released one another from liabilities and damages related to the transaction documents, any breaches, and the proposed business combination. Launch One and its sponsor currently intend to look for alternative ways to complete an initial business combination in the future.
Launch One Acquisition Corp. (LPAA) filed its quarterly report and detailed progress toward its proposed merger with Minovia. For the quarter ended September 30, 2025, the SPAC reported net income of $2,011,042, driven largely by interest earned on its Trust Account. General and administrative expenses were $517,261, while interest on cash and marketable securities held in the Trust Account was $2,556,473.
The Trust Account held $243,082,744, equating to $10.56 per Public Share as of September 30, 2025. Management disclosed a working capital deficit of $332,033 and noted that the Combination Period governs the time to complete a business combination, with substantial doubt about the company’s ability to continue as a going concern if no deal closes within that period. The Minovia Business Combination Agreement sets total consideration of $180 million plus certain financing proceeds, payable in Pubco shares at the Redemption Price, and includes up to $57.5 million of contingent earnout shares, subject to specified share price or clinical milestones, and a $23 million minimum cash condition at closing.